Controlling calcium compound formation in biocompatible materials for tissue regeneration and repair in mammals

US9561303B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9561303-B2
Application numberUS-201213543115-A
CountryUS
Kind codeB2
Filing dateJul 6, 2012
Priority dateJan 6, 2010
Publication dateFeb 7, 2017
Grant dateFeb 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A biocompatible composition for tissue repair or regeneration in mammals comprising one or more glass former compounds selected from the group consisting of B 2 O 3 , P 2 O 5 , and SiO 2 and director elements selected from the group consisting of Cu, Sr, Zn, Fe, Mn, Cr, V, Nb, Mo, W, Ba, Co, S, Al, Ti, Y, Mg, Si and/or Ni to promote in vivo calcium compound formation of calcium carbonate or other calcium compounds other than hydroxyapatite. Upon direct application of the biocompatible composition to a mammalian host, calcium carbonate or other calcium compounds other than hydroxyapatite form upon bioreaction of the composition with bodily fluids.

First claim

Opening claim text (preview).

The invention claimed is: 1. A biocompatible composition for tissue repair or regeneration in mammals comprising: 40 to 80 wt % B 2 O 3 ; 2.5 to 50 wt % CaO; one or more of MgO, SrO, and combinations thereof in a cumulative concentration of 5 to 40 wt %; one or more of Li 2 O, Na 2 O, K 2 O, Rb 2 O and combinations thereof; one or more director elements selected from the group consisting of Cu, Zn, Fe, Mn, Ba, Co, S, V, and/or Y in a cumulative concentration between 0.05 and 5 wt % to promote in vivo calcium compound formation of calcium carbonate or other calcium-containing materials other than hydroxyapatite; wherein upon direct application of the biocompatible composition to a mammalian host, calcium carbonate or other calcium-containing materials other than hydroxyapatite form upon bioreaction of the composition with bodily fluids; wherein the composition is in a form of one or more of fibers, hollow fibers, tubes, ribbons, solid spheres, hollow spheres, particles, bonded particles, and combinations thereof assembled in a scaffold which has a porosity of between about 15 and about 90 vol % with at least about 75 vol % of pores being interconnected and suitable for application to a mammalian host such that it is exposed to the mammalian host's bodily fluids for tissue repair or regeneration in mammals; and wherein the composition is not water soluble. 2. The biocompatible composition of claim 1 wherein said calcium carbonate or other calcium-containing materials other than hydroxyapatite that forms upon bioreaction of the composition with bodily fluids comprises calcite; and wherein hydroxyapatite also forms upon bioreaction of the composition with bodily fluids. 3. The biocompatible composition of claim 1 wherein hydroxyapatite does not form upon bioreaction of the composition with bodily fluids. 4. The biocompatible composition of claim 3 wherein the director element is selected from the group consisting of Cu, Zn, Fe, Mn, Ba, Co, and/or S. 5. The biocompatible composition of claim 3 wherein the director element is selected from the group consisting of Cu, Mn, Ba, Co, and/or S. 6. The biocompatible composition of claim 3 wherein the director element is Zn and/or Fe. 7. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 said one or more director elements; said one or more of Li 2 O, Rb 2 O, SiO 2 , Al 2 O 3 , and F. 8. The biocompatible composition of claim 1 consisting of approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 and said one or more director elements, one or more of Li 2 O, Rb 2 O, SiO 2 , Al 2 O 3 , and F. 9. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 12 to 24 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 0.1 to 2.5 wt % CuO. 10. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 0.1 to 2.5 wt % CuO. 11. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 0.1 to 2.5 wt % CuO 0.1 to 2.5 wt % ZnO. 12. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 0.1 to 2.5 wt % CuO 0.1 to 2.5 wt % ZnO 0.1 to 2.5 wt % Fe 2 O 3 wherein the one or more director elements is supplied by said CuO, ZnO, and/or Fe 2 O 3 . 13. A biocompatible composition for tissue repair or regeneration in mammals comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 one or more director elements selected from the group consisting of Cu, Zn, Fe, Mn, Ba, Co, S, V, and/or Y in a cumulative concentration between 0.05 and 5 wt % to promote in vivo calcium compound formation of calcium carbonate or other calcium-containing materials other than hydroxyapatite; optionally one or more of Li 2 O, Rb 2 O, SiO 2 , Al 2 O 3 , and F; wherein the composition is in the form of a scaffold of glass fibers; wherein the scaffold has a porosity of between about 15 and about 90 vol % with at least about 75 vol % of pores being interconnected; wherein the glass fibers have lengths between about 2 and about 150 mm and a length:diameter aspect ratio of at least 5:1; wherein the composition is not water soluble. 14. The biocompatible composition of claim 3 wherein the composition comprises from 10 to 90 wt % of components having one composition and from 10 to 90 wt % of components of a different composition. 15. The biocompatible composition of claim 3 wherein the composition is in the form of fibers and spheres. 16. The biocompatible composition of claim 1 wherein the one or more director elements are Zn and Fe. 17. The biocompatible composition of claim 1 wherein the one or more director elements is Zn. 18. The biocompatible composition of claim 1 wherein the one or more director elements is Fe. 19. The composition of claim 1 comprising fibers having a diameter between 20 and 5000 microns. 20. The composition of claim 1 comprising fibers having a diameter between 100 and 300 microns. 21. The composition of claim 1 comprising particles having a particle size in the range of 150 to 300 microns.

Assignees

Inventors

Classifications

  • A61L27/10Primary

    Ceramics or glasses · CPC title

  • Materials at least partially resorbable by the body · CPC title

  • Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9561303B2 cover?
A biocompatible composition for tissue repair or regeneration in mammals comprising one or more glass former compounds selected from the group consisting of B 2 O 3 , P 2 O 5 , and SiO 2 and director elements selected from the group consisting of Cu, Sr, Zn, Fe, Mn, Cr, V, Nb, Mo, W, Ba, Co, S, Al, Ti, Y, Mg, Si and/or Ni to promote in vivo calcium compound formation of calcium carbonate or ot…
Who is the assignee on this patent?
Jung Steven B, Day Delbert E, Univ Missouri
What technology area does this patent fall under?
Primary CPC classification A61L27/10. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).